BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35887203)

  • 1. Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer.
    Rupp B; Owen S; Ball H; Smith KJ; Gunchick V; Keller ET; Sahai V; Nagrath S
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
    Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG
    Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
    Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
    PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer.
    Malihi PD; Graf RP; Rodriguez A; Ramesh N; Lee J; Sutton R; Jiles R; Ruiz Velasco C; Sei E; Kolatkar A; Logothetis C; Navin NE; Corn P; Aparicio AM; Dittamore R; Hicks J; Kuhn P; Zurita AJ
    Clin Cancer Res; 2020 Aug; 26(15):4143-4153. PubMed ID: 32341031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.
    Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G
    Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch
    Neumann MH; Schneck H; Decker Y; Schömer S; Franken A; Endris V; Pfarr N; Weichert W; Niederacher D; Fehm T; Neubauer H
    Biotechnol Prog; 2017 Jan; 33(1):125-132. PubMed ID: 27126369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A workflow for the enrichment, the identification, and the isolation of non-apoptotic single circulating tumor cells for RNA sequencing analysis.
    Abramova A; Rivandi M; Yang L; Stamm N; Cieslik JP; Honisch E; Niederacher D; Fehm T; Neubauer H; Franken A
    Cytometry A; 2024 Apr; 105(4):242-251. PubMed ID: 38054742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
    Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
    Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients.
    Acheampong E; Morici M; Abed A; Bowyer S; Asante DB; Lin W; Millward M; Gray ES; Beasley AB
    J Cancer Res Clin Oncol; 2023 May; 149(5):1941-1950. PubMed ID: 35896898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms.
    Childs A; Steele CD; Vesely C; Rizzo FM; Ensell L; Lowe H; Dhami P; Vaikkinen H; Luong TV; Conde L; Herrero J; Caplin M; Toumpanakis C; Thirlwell C; Hartley JA; Pillay N; Meyer T
    Endocr Relat Cancer; 2021 Aug; 28(9):631-644. PubMed ID: 34280125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Activating Estrogen Receptor Gene (
    Paolillo C; Mu Z; Rossi G; Schiewer MJ; Nguyen T; Austin L; Capoluongo E; Knudsen K; Cristofanilli M; Fortina P
    Clin Cancer Res; 2017 Oct; 23(20):6086-6093. PubMed ID: 28679775
    [No Abstract]   [Full Text] [Related]  

  • 15. A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity.
    Deger T; Mendelaar PAJ; Kraan J; Prager-van der Smissen WJC; van der Vlugt-Daane M; Bindels EMJ; Sieuwerts AM; Sleijfer S; Wilting SM; Hollestelle A; Martens JWM
    Mol Oncol; 2022 Aug; 16(16):2981-3000. PubMed ID: 34964258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions.
    Yang L; Rivandi M; Franken A; Hieltjes M; van der Zaag PJ; Nelep C; Eberhardt J; Peter S; Niederacher D; Fehm T; Neubauer H
    Cytometry A; 2022 Dec; 101(12):1057-1067. PubMed ID: 35698878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.
    Magbanua MJ; Sosa EV; Scott JH; Simko J; Collins C; Pinkel D; Ryan CJ; Park JW
    BMC Cancer; 2012 Feb; 12():78. PubMed ID: 22373240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
    Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
    Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.
    Premasekharan G; Gilbert E; Okimoto RA; Hamirani A; Lindquist KJ; Ngo VT; Roy R; Hough J; Edwards M; Paz R; Foye A; Sood R; Copren KA; Gubens M; Small EJ; Bivona TG; Collisson EA; Friedlander TW; Paris PL
    Cancer Lett; 2016 Sep; 380(1):144-52. PubMed ID: 27343980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.